18 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/18/3027655/25619/en/Chimerix-Announces-FDA-Acceptance-and-Priority-Review-of-New-Drug-Application-for-Dordaviprone-as-Treatment-for-Recurrent-H3-K27M-Mutant-Diffuse-Glioma.html